l Investigation of Robotic-assisted TKA (RA-TKA) With Skywalker and Evolution Medial Pivot Knee (eMP Knee)

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18-95
SponsorOrthopaedic Department of General University Hospital of Laria

About this trial

This is a prospective trial that attempts to develop evidence on the safety and performance of RA-TKA (Robotic-assisted total knee arthroplasty) with Skywalker and eMP (Evolution Medial Pivot) knee. Moreover to evaluate performance of eMP patients with Skywalker (in comparison to eMP with conventional instrumentations and non-MP TKAs)

Eligibility criteria

This trial accepts healthy volunteers

Qualifiers

>= 18 Years Male or Female

With noninflammatory degenerative joint disease, inflammatory joint disease, functional deformity

The subject has signed the Ethical Board approved Informed Consent Form specific to this study prior to enrollment

Must be independent, ambulatory, and can comply with all post-operative evaluations and visits.

Disqualifiers

Subjects with poor compliance, unable to complete the trial according to the requirements or for other reasons or considered not to be suitable for inclusion by investigators.

Concurrent participation in any other total hip or knee replacement studies.

Trial design

Design model

Parallel

Treatments tested in this trial

  • Robotic TKA

    Procedure/Surgery

    Total knee replacement of arthritic knees either with robotic-assisted Skywalker device

  • Conventional TKA

    Procedure/Surgery

    Total knee replacement of arthritic knees performed manually

Treatment groups

122 Participants
are divided into 2 treatment groups
Group A: Robotic-assisted Skywalker device - Evolution Medial PivotActive comparator 1 intervention
Group B: Conventional total knee arthroplasty with manual instruments - device - Evolution Medial PivotActive comparator 0 interventions

Trial outcomes

Primary outcomes

1

Primary Effectiveness Endpoints with outcome scores Primary Effectiveness Endpoints

KOOS score(Knee Injury and Osteoarthritis Outcome Score) with a 0-100 scale measured at 1, 3, 6 and 12 months

Time frame
2 years after intervention
2

Primary Effectiveness Endpoints with outcome scores Primary Effectiveness Endpoints

FJS (Forgotten Joint Score) with a scale 0 to 48 score measured at 1, 3, 6, and 12 months

Time frame
2 years after intervention
3

Primary Effectiveness Endpoints with outcome scores Primary Effectiveness Endpoints

VAS score (Visual Analogue Scale) with a 0-10 scale measured at 1, 3, 6 and 12 months

Time frame
2 years after intervention
4

Primary Effectiveness Endpoints with outcome scores Primary Effectiveness Endpoints

OKS score(Oxford Knee Score) with a 0-100 scale measured at 1, 3, 6 and 12 months

Time frame
2 years after intervention

Secondary outcomes

1

Accuracy of implantation measured in degrees of correction

Accuracy based on planned vs actual size and alignment parameters

Time frame
1 year after intervention
2

Learning curve

Learning curve based on surgical time

Time frame
1 year after intervention

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.